Detalhe da pesquisa
1.
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
Int J Cancer
; 146(6): 1643-1651, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31318983
2.
Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 14(2): 149-58, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23306100
3.
A Randomized, Open-label, Cross-over Phase 2 Trial of Darolutamide and Enzalutamide in Men with Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer: Patient Preference and Cognitive Function in ODENZA.
Eur Urol
; 85(3): 274-282, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37271630
4.
Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma.
Eur J Cancer
; 108: 33-40, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30616146
5.
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.
JAMA Oncol
; 5(5): 623-632, 2019 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30703190
6.
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study.
Eur J Cancer
; 80: 55-62, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28549248
7.
Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial.
Eur Urol
; 70(2): 256-62, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26610858
8.
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2.
Eur J Cancer
; 51(1): 45-54, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25459391
9.
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Eur Urol
; 68(2): 196-204, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25277272
10.
Erratum to 'Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma' [Eur J Cancer 108 (February 2019) 33-40].
Eur J Cancer
; 119: 200-201, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31301937
11.
Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15).
Eur J Cancer
; 50(5): 953-62, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24424105
12.
Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Génitales) study.
J Urol
; 177(5): 1698-702, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17437788